Stock listing
INAF Stock Price, News, Filings & Events — Pt Indofarma Tbk Class B
Selected listing: INAF · IDX · IDR · ID
This page tracks Pt Indofarma Tbk Class B's INAF:IDX listing on IDX in IDR for ID, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following INAF:IDX. INAF:IDX is the stock-level entry point for investors researching Pt Indofarma Tbk Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pt Indofarma Tbk Class B, traded under the ticker INAF, is a public company based in Indonesia. With a market capitalization of approximately 21.48 million, the company operates in the pharmaceutical sector. Its focus is on providing healthcare solutions and products to meet the needs of the Indonesian market.

- Ticker
- INAF:IDX
- Asset type
- Stock
- Market cap
- $22.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- IDX
- Currency
- IDR
Pt Indofarma Tbk Class B INAF:IDX stock context
This page tracks Pt Indofarma Tbk Class B's INAF:IDX listing on IDX in IDR for ID, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following INAF:IDX. INAF:IDX is the stock-level entry point for investors researching Pt Indofarma Tbk Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pt Indofarma Tbk Class B, traded under the ticker INAF, is a public company based in Indonesia. With a market capitalization of approximately 21.48 million, the company operates in the pharmaceutical sector. Its focus is on providing healthcare solutions and products to meet the needs of the Indonesian market.
Latest news from Pt Indofarma Tbk Class B
Monthly Report of Securities Holders Registration
August 3, 2026
REPORT OF OWNERSHIP OR ANY CHANGES IN SHARE OWNERSHIP OF PUBLIC COMPANIES
July 19, 2026
Realization of the Recovery Plan for the Causes of Suspension
June 30, 2026
Public Expose Report Disclosure - Annual
June 29, 2026
Public Expose Material Submission - Annual
June 20, 2026
Research Pt Indofarma Tbk Class B
Pt Indofarma Tbk Class B investor report
Review AI stock analysis and investor report context for INAF:IDX.
Pt Indofarma Tbk Class B company profile
View the public company page for Pt Indofarma Tbk Class B on 6ix.
Pt Indofarma Tbk Class B news
Read company news and market updates connected to Pt Indofarma Tbk Class B.
Pt Indofarma Tbk Class B investor events
Find investor webinars, events, and replay context for Pt Indofarma Tbk Class B.